Armistice Capital, LLC 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 4:56 pm Sale |
2024-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Armistice Capital, LLC | 188,438 4.990% |
-131,318![]() (-41.07%) |
Filing |
2024-11-14 5:03 pm Purchase |
2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS |
Armistice Capital, LLC | 319,756 9.990% |
319,756![]() (New Position) |
Filing |